Pune, India – September 24, 2026 -- The global placenta market is set to nearly triple from USD 96.1 billion in 2025 to USD 275.18 billion by 2034, expanding at a 12.4% compound annual growth rate, according to a new analysis by Maximize Market Research.
Asia-Pacific leads global demand as Japan, South Korea and China drive placenta research
Asia-Pacific held the leading market position in 2025, backed by strong placenta research and development in Japan, South Korea and China, alongside rising production of placenta-derived products for pharmaceutical and cosmetics applications. The region's large consumer base and appetite for anti-aging and skincare solutions continue to underpin its dominant position.
Cosmetics segment fuels growth as placenta extracts enter creams and serums
Placenta-based cosmetics are gaining traction as manufacturers incorporate placenta extracts into creams, serums, skincare formulations and hair-care products. Porcine placenta remains the most established source type, while equine, ovine and other sources are diversifying product portfolios across pharmaceutical, cosmetics and dietary supplement uses. Products are being developed in powder, liquid and gel forms to serve these varied applications.
North America and Europe emerge as growth markets for placenta-derived formulations
North America, led by the United States and Canada, is expanding biotechnology research and commercialization of placenta-derived products. In Europe, the United Kingdom, France, Germany, Italy, Spain, Sweden and Austria are contributing to demand for premium skincare, anti-aging formulations and pharmaceutical research, with regulatory compliance and product quality shaping market development.
Regulatory complexity and sourcing ethics pose constraints on market expansion
Ethical concerns over placenta sourcing and utilization, combined with varying regulations for animal-derived ingredients across pharmaceuticals, cosmetics and dietary supplements, are increasing compliance burdens for manufacturers. Limited standardization in extraction methods and processing technologies across porcine, equine and ovine sources is also creating product consistency challenges that could affect consumer acceptance in developing regions.
Emerging regions see rising interest in placenta-based wellness products
Middle East & Africa, including GCC countries, South Africa, Egypt and Nigeria, is emerging as a market for placenta-based cosmetics and supplements amid improving distribution networks. South America, led by Brazil and Argentina, is also seeing growing interest in placenta extracts for beauty and wellness applications.
Key industry players named in competitive landscape
Companies identified as strengthening the placenta market landscape include Agri-Lab Co-Products, TelaGen, Japan Natural Laboratories Co., Ltd., and MiMedx Group, Inc.